Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/82179
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFarrugia, Francesca-
dc.contributor.authorAbela, Marisa-
dc.date.accessioned2021-10-14T06:56:24Z-
dc.date.available2021-10-14T06:56:24Z-
dc.date.issued2021-10-
dc.identifier.citationFarrugia, F., & Abela, M. (2021). Ertapenem-induced delirium. Malta Medical Journal, 33(2), 111-113.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/82179-
dc.description.abstractIntroduction: Ertapenem is an intravenous antibiotic within the class of carbapenem antibiotics which are highly effective against severe bacterial infections. These antibiotic agents exhibit a wider spectrum of action when compared to penicillins and cephalosporins despite carbapenems being part of the beta-lactam antibiotic class.en_GB
dc.description.abstractCase presentation: The patient is an 85-year old gentleman who developed a lower urinary tract infection and left 4th toe osteomyelitis. Ertapenem was prescribed according to the sensitivities of the cultured organisms. After two weeks of antibiotic treatment the patient developed new-onset delirium, agitation, hallucinations and throat discomfort. Ertapenem was stopped and the new symptoms resolved within 48 hours.en_GB
dc.description.abstractDiscussion: Delirium, agitation, hallucinations and throat discomfort are rare but documented side-effects of ertapenem. In such cases the withdrawal of ertapenem results in a resolution of symptoms.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Medical Schoolen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectErtapenemen_GB
dc.subjectLactams -- Physiological effecten_GB
dc.subjectDeliriumen_GB
dc.titleErtapenem-induced deliriumen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.publication.titleMalta Medical Journalen_GB
Appears in Collections:MMJ, Volume 33, Issue 2
MMJ, Volume 33, Issue 2

Files in This Item:
File Description SizeFormat 
MMJ33(2)CR2.pdf295.67 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.